Nova Eye Medical (AU:EYE) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Nova Eye Medical Limited reported a significant increase in revenues up by 37% to $A 23,325 for the fiscal year ended 30 June 2024, but also a notable decrease in losses, with a 48% reduction in net loss before tax to $A 8,790. Despite the increased revenues, the company did not declare any dividends for the period and reported a slight decrease in net tangible asset backing per security from 4.4 cents to 4.3 cents.
For further insights into AU:EYE stock, check out TipRanks’ Stock Analysis page.
